Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant ...

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface ...

A man with a severe speech disability is able to speak expressively and sing using a brain implant that translates his neural ...

Paradromics completes first human BCI implant, setting stage for clinical trials targeting severe motor impairment.

Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient ...

Paradromics implanted its first brain implant device, Connexus, in a human patient last month, successfully recording ...

Hospitals are testing brain-computer interface technology, which shows promise in helping motor-impaired patients communicate ...

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Neuralink raised $650M in Series E funding to advance brain-computer tech, with global trials and new use cases now underway.

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

The procedure took place at the University of Michigan with a patient who was already undergoing neurosurgery to treat ...

Neurotech startup Paradromics has completed its first brain implant after nearly three years of preclinical studies. The ...